STRATA CRITICAL MEDICAL, INC.
STRATA CRITICAL MEDICAL, INC.
NEW YORK, NY
Loading...
Price History
Market Data
| Market Cap | 466.26M |
| P/E Ratio | 10.94 |
| P/B Ratio | 1.67 |
| EPS | 0.49 |
| Dividend Yield | - |
| D/E Ratio | 0.17 |
| Current Ratio | 6.38 |
| Currency | USD |
Key Financial Metrics
241.19M
Revenue
41.35M
Net Income
0.49
EPS (Diluted)
-69.60M
Free Cash Flow
Profitability
Gross Margin
22.0%
Operating Margin
-10.2%
Net Profit Margin
17.1%
EBITDA
-11.21M
Returns & Efficiency
Return on Assets (ROA)
12.7%
Return on Equity (ROE)
14.8%
Dividend Yield
-
EPS
0.49
Financial Health
Total Assets
325.47M
Total Debt
-
Debt to Equity
0.17x
Current Ratio
6.38
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Business Services |
| HQ | NEW YORK, NY |
| Fiscal Year | 2025 |
Peers
MITESCO, INC.
MITI
937.63B
P/E: --
3.02B
P/E: 111.2
2.88B
P/E: --
PENNANT GROUP, INC.
PNTG
1.14B
P/E: 35.5
1.12B
P/E: 52.6
1.10B
P/E: 158.2
1.10B
P/E: 158.2
OMADA HEALTH, INC.
OMDA
940.25M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$466.26M
P/E Ratio (TTM)10.9
Price to Book1.67
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin22.0%
Operating Margin-10.2%
Net Margin17.1%
ROE14.8%
ROA12.7%
Leverage & Liquidity
Debt to Equity0.17
Current Ratio6.38
Total Debt-
Total Assets$325.47M
Stockholders' Equity$279.07M
Income Statement (FY 2025)
Revenue$241.19M
Gross Profit$53.00M
Operating Income$-24.56M
Net Income$41.35M
EPS (Diluted)$0.49
Cash Flow (FY 2025)
Free Cash Flow$-69.60M
Cash & Equivalents$30.97M
Revenue Growth22.3%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 31 HUDSON YARDS 14TH FLOOR NEW YORK, NY 10001 |
| Phone | 212-967-1009 |
| Incorporated | DE, US |
| EIN | 841890381 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 86.99M |
| Stockholders' Equity | $279.07M |
| Cash & Equivalents | $30.97M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-04-16
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-14
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-14
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-04-08
Local
SCHEDULE 13D
Beneficial Ownership Report
Schedule 13D - beneficial ownership over 5%
Filed: 2026-04-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | STRATA CRITICAL MEDICAL, INC. |
| Ticker | SRTA |
| Exchange | -- |
| Sector | Services |
| Industry | Business Services |
| Headquarters | NEW YORK, NY |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 466.26M |
| Revenue | 241.19M |
| Net Income | 41.35M |
| P/E Ratio | 10.94 |
| EPS | 0.49 |
| Net Margin | 17.1% |
| ROE | 14.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...